vs
Side-by-side financial comparison of ACNB CORP (ACNB) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $47.2M, roughly 1.3× ACNB CORP). ACNB CORP runs the higher net margin — 22.9% vs -16.4%, a 39.3% gap on every dollar of revenue. On growth, ACNB CORP posted the faster year-over-year revenue change (42.2% vs 17.0%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $9.7M). Over the past eight quarters, ACNB CORP's revenue compounded faster (22.1% CAGR vs 17.4%).
ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
ACNB vs KIDS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $61.6M |
| Net Profit | $10.8M | $-10.1M |
| Gross Margin | — | 73.2% |
| Operating Margin | 27.9% | -13.3% |
| Net Margin | 22.9% | -16.4% |
| Revenue YoY | 42.2% | 17.0% |
| Net Profit YoY | 63.8% | 37.1% |
| EPS (diluted) | $1.10 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.2M | $61.6M | ||
| Q3 25 | $50.9M | $61.3M | ||
| Q2 25 | $50.3M | $61.1M | ||
| Q1 25 | $43.5M | $52.4M | ||
| Q4 24 | $33.2M | $52.7M | ||
| Q3 24 | $34.1M | $54.6M | ||
| Q2 24 | $33.3M | $52.8M | ||
| Q1 24 | $31.6M | $44.7M |
| Q4 25 | $10.8M | $-10.1M | ||
| Q3 25 | $14.9M | $-11.8M | ||
| Q2 25 | $11.6M | $-7.1M | ||
| Q1 25 | $-272.0K | $-10.7M | ||
| Q4 24 | $6.6M | $-16.1M | ||
| Q3 24 | $7.2M | $-7.9M | ||
| Q2 24 | $11.3M | $-6.0M | ||
| Q1 24 | $6.8M | $-7.8M |
| Q4 25 | — | 73.2% | ||
| Q3 25 | — | 73.9% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 73.4% | ||
| Q2 24 | — | 77.3% | ||
| Q1 24 | — | 72.0% |
| Q4 25 | 27.9% | -13.3% | ||
| Q3 25 | 37.2% | -15.4% | ||
| Q2 25 | 29.7% | -17.4% | ||
| Q1 25 | -1.3% | -21.0% | ||
| Q4 24 | 24.8% | -26.7% | ||
| Q3 24 | 27.6% | -10.2% | ||
| Q2 24 | 42.8% | -10.7% | ||
| Q1 24 | 26.9% | -21.8% |
| Q4 25 | 22.9% | -16.4% | ||
| Q3 25 | 29.2% | -19.2% | ||
| Q2 25 | 23.2% | -11.6% | ||
| Q1 25 | -0.6% | -20.3% | ||
| Q4 24 | 19.9% | -30.5% | ||
| Q3 24 | 21.1% | -14.5% | ||
| Q2 24 | 33.9% | -11.4% | ||
| Q1 24 | 21.4% | -17.5% |
| Q4 25 | $1.10 | $-0.43 | ||
| Q3 25 | $1.42 | $-0.50 | ||
| Q2 25 | $1.11 | $-0.30 | ||
| Q1 25 | $-0.03 | $-0.46 | ||
| Q4 24 | $0.77 | $-0.70 | ||
| Q3 24 | $0.84 | $-0.34 | ||
| Q2 24 | $1.32 | $-0.26 | ||
| Q1 24 | $0.80 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $60.9M |
| Total DebtLower is stronger | $255.4M | $106.0M |
| Stockholders' EquityBook value | $420.0M | $346.6M |
| Total Assets | $3.2B | $508.6M |
| Debt / EquityLower = less leverage | 0.61× | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $60.9M | ||
| Q3 25 | $102.1M | $57.7M | ||
| Q2 25 | $103.1M | $70.1M | ||
| Q1 25 | $123.6M | $58.8M | ||
| Q4 24 | $47.3M | $68.8M | ||
| Q3 24 | $58.1M | $76.1M | ||
| Q2 24 | $86.3M | $28.9M | ||
| Q1 24 | $53.1M | $47.7M |
| Q4 25 | $255.4M | $106.0M | ||
| Q3 25 | $255.4M | $105.3M | ||
| Q2 25 | $255.4M | $102.7M | ||
| Q1 25 | $255.3M | $77.4M | ||
| Q4 24 | $255.3M | $77.5M | ||
| Q3 24 | $255.3M | $76.9M | ||
| Q2 24 | $255.3M | $11.2M | ||
| Q1 24 | $255.3M | $11.3M |
| Q4 25 | $420.0M | $346.6M | ||
| Q3 25 | $408.6M | $349.3M | ||
| Q2 25 | $395.2M | $355.5M | ||
| Q1 25 | $386.9M | $347.1M | ||
| Q4 24 | $303.3M | $354.6M | ||
| Q3 24 | $306.8M | $370.9M | ||
| Q2 24 | $289.3M | $371.3M | ||
| Q1 24 | $279.9M | $370.6M |
| Q4 25 | $3.2B | $508.6M | ||
| Q3 25 | $3.3B | $493.5M | ||
| Q2 25 | $3.3B | $503.6M | ||
| Q1 25 | $3.3B | $470.3M | ||
| Q4 24 | $2.4B | $473.2M | ||
| Q3 24 | $2.4B | $489.3M | ||
| Q2 24 | $2.5B | $430.8M | ||
| Q1 24 | $2.4B | $437.2M |
| Q4 25 | 0.61× | 0.31× | ||
| Q3 25 | 0.62× | 0.30× | ||
| Q2 25 | 0.65× | 0.29× | ||
| Q1 25 | 0.66× | 0.22× | ||
| Q4 24 | 0.84× | 0.22× | ||
| Q3 24 | 0.83× | 0.21× | ||
| Q2 24 | 0.88× | 0.03× | ||
| Q1 24 | 0.91× | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.6M | $10.3M |
| Free Cash FlowOCF − Capex | $52.6M | $9.7M |
| FCF MarginFCF / Revenue | 111.4% | 15.8% |
| Capex IntensityCapex / Revenue | 2.3% | 1.0% |
| Cash ConversionOCF / Net Profit | 4.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.6M | $10.3M | ||
| Q3 25 | $23.2M | $-581.0K | ||
| Q2 25 | $17.8M | $-10.5M | ||
| Q1 25 | $-71.0K | $-4.2M | ||
| Q4 24 | $39.8M | $-4.0M | ||
| Q3 24 | $13.6M | $-10.3M | ||
| Q2 24 | $9.7M | $-6.1M | ||
| Q1 24 | $10.8M | $-6.7M |
| Q4 25 | $52.6M | $9.7M | ||
| Q3 25 | $22.8M | $-3.4M | ||
| Q2 25 | $17.6M | $-13.9M | ||
| Q1 25 | $-730.0K | $-8.4M | ||
| Q4 24 | $38.8M | $-4.2M | ||
| Q3 24 | $13.3M | $-11.7M | ||
| Q2 24 | $9.4M | $-12.8M | ||
| Q1 24 | $10.7M | $-13.2M |
| Q4 25 | 111.4% | 15.8% | ||
| Q3 25 | 44.7% | -5.6% | ||
| Q2 25 | 35.0% | -22.8% | ||
| Q1 25 | -1.7% | -16.0% | ||
| Q4 24 | 117.0% | -8.1% | ||
| Q3 24 | 39.1% | -21.4% | ||
| Q2 24 | 28.3% | -24.2% | ||
| Q1 24 | 33.9% | -29.4% |
| Q4 25 | 2.3% | 1.0% | ||
| Q3 25 | 0.8% | 4.6% | ||
| Q2 25 | 0.4% | 5.6% | ||
| Q1 25 | 1.5% | 8.1% | ||
| Q4 24 | 2.9% | 0.5% | ||
| Q3 24 | 0.7% | 2.5% | ||
| Q2 24 | 0.9% | 12.7% | ||
| Q1 24 | 0.2% | 14.5% |
| Q4 25 | 4.96× | — | ||
| Q3 25 | 1.56× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.03× | — | ||
| Q3 24 | 1.88× | — | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | 1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
